Pushing Cancer Over The Edge
After many disappointing studies, PARP inhibitors are finally showing promise as killers of cells already damaged by mutations
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
June 17, 2013 Cover
Volume 91, Issue 24
After many disappointing studies, PARP inhibitors are finally showing promise as killers of cells already damaged by mutations
Cover image:
Credit:
After many disappointing studies, PARP inhibitors are finally showing promise as killers of cells already damaged by mutations
Radical restructuring proposed for federal science education funding has the community scrambling
Microscopy points to precise color of railcar, but spectroscopy may be needed to confirm results
Synthesis of lanthanide(II) compounds may lead to other chemical transformations
Transformation via new energy source will come gradually, chemical executives say
For 75 years, the Industrial Research Institute has been fostering collaboration among its members
With rigid wings and a flexible core, a new compound can switch between two conformations and glow one of three colors